Auris Medical Holding Insiders

Auris Medical employs about 8 people. The company is managed by 17 executives with a total tenure of roughly 152 years, averaging almost 8.0 years of service per executive, having 0.47 employees per reported executive. Breaking down Auris Medical's management performance can provide insight into the firm performance.
James Healy  Chairman
Non-Executive Independent Vice Chairman of the Board
Thomas Meyer  Chairman
Founder, Chairman, CEO and Managing Director
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Auris Medical Management Team Effectiveness

The company has return on total asset (ROA) of (21.99) % which means that it has lost $21.99 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (71.91) %, meaning that it created substantial loss on money invested by shareholders. Auris Medical's management efficiency ratios could be used to measure how well Auris Medical manages its routine affairs as well as how well it operates its assets and liabilities.

Auris Medical Workforce Comparison

Auris Medical Holding is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 19,761. Auris Medical adds roughly 8.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Auris Medical Notable Stakeholders

An Auris Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Auris Medical often face trade-offs trying to please all of them. Auris Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Auris Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James HealyNon-Executive Independent Vice Chairman of the BoardProfile
Thomas MeyerFounder, Chairman, CEO and Managing DirectorProfile
Hernan LevettCFOProfile
Sven ZimmermannCFOProfile
Calvin RobertsNon-Executive Independent DirectorProfile
Mats BlomDirectorProfile
Antoine PapiernikNon-Executive Independent DirectorProfile
Berndt ModigNon-Executive Independent DirectorProfile
Armando AnidoNon-Executive Independent DirectorProfile
Alain MunozDirectorProfile
Cindy McGeeHead of Investor Relations and Corporate CommunicationsProfile
Bettina StubinskiChief Medical OfficerProfile
Wolfgang ArnoldBoard MemberProfile
Oliver KubliBoard MemberProfile
Thomas JungChief Development OfficerProfile
Andrea BraunHead of Regulatory and Quality AffairsProfile
Anne ZollerGeneral CounselProfile

Auris Medical Workforce Analysis

Traditionally, organizations such as Auris Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Auris Medical within its industry.

Auris Medical Manpower Efficiency

Return on Auris Medical Manpower

Revenue Per Employee21.8K
Revenue Per Executive10.3K
Net Loss Per Employee1M
Net Loss Per Executive482.4K
Working Capital Per Employee3.9M
Working Capital Per Executive1.8M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Auris Stock

If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets